New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal

Details for Australian Patent Application No. 2006222312 (hide)

Owner Alfa Wassermann S.p.A.

Inventors Barbanti, Maria Miriam; Braga, Dario; Campana, Manuela; Viscomi, Giuseppe Claudio; Confortini, Donatella

Agent Lord and Company

Pub. Number AU-B-2006222312

PCT Pub. Number WO2006/094662

Priority 05004695.2 03.03.05 EP

Filing date 27 February 2006

Wipo publication date 14 September 2006

Acceptance publication date 3 November 2011

International Classifications

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/094662 Priority application(s): WO2006/094662

3 November 2011 Application Accepted

  Published as AU-B-2006222312

17 November 2011 Corrigenda

  Applications Accepted - Name Index Under the name Alfa Wassermann S.p.A., Application No. 2006222312, under INID (31) correct the number to read 05004695.2

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222314-Endoparasiticide

2006222298-Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine